aducanumab – Mayo Clinic News Network

Trending/aducanumab

an elderly white man with grey hair looking sad, worried, forgetful holding his head with his hands

By Jennifer O'Hara
June 15, 2021
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

Mayo Clinic Q&A podcast: Mayo Clinic experts discuss new Alzheimer’s treatment option

Last week, the Food and Drug Administration approved aducanumab to treat Alzheimer’s disease, which is a progressive brain disorder that is the most common cause…

Alzheimer disease, neuron network with amyloid plaques

By Susan Barber Lindquist
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

June 7, 2021

FDA approves aducanumab to treat Alzheimer’s disease

Senior woman and doctor writing on clipboard in hospital room

By Dana Sparks
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

December 5, 2019

Drugmaker presents data on new Alzheimer’s drug

Senior woman and doctor writing on clipboard in hospital room

By Jason Howland
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

October 22, 2019

New Alzheimer’s drug to be submitted to FDA for approval

Special Topics

Sign up

image description

For Journalists Only Sign up for a Media Pass

Social Media Network

A network for digital healthcare communicators

Mayo Clinic Connect

An online patient support community

version 3.3.6.2.5.9
Page loaded in 0.147 seconds